daratumumab,talquetamab,teclistamab
genmab,janssen
['talquetamab', 'redirectt-1', 'multiple myeloma', 'teclistamab']
watch: yael cohen, md, discusses primary efficacy findings from the phase 1/2 redirectt-1 trial, which is investigating the combination of teclistamab and talquetamab in r/r multiple myeloma. #asco23 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.